Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: Role of the D1 receptor

Behavioural Brain Research

Volumn 232, Issue 1, 2012, Pages 30-36

  Zager, Adriano ^a   Mennecier, Gregory ^a   Palermo Neto, João ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amphetamine; Behavioral sensitization; D1 dopamine receptor; Late gestation; Maternal immune activation; Mesolimbic pathway; Prenatal LPS

Indexed keywords

AMPHETAMINE; DOPAMINE 1 RECEPTOR; ESCHERICHIA COLI LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GROOMING; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PROTEIN FUNCTION; RECEPTOR UPREGULATION; THIRD TRIMESTER PREGNANCY;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; FEMALE; IMMUNITY; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; MALE; MICE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, DOPAMINE D1; UP-REGULATION;

EID: 84859758549     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.03.036     Document Type: Article

References (64)

1. Arndt T.L., Stodgell C.J., Rodier P.M. The teratology of autism. Int J Dev Neurosci 2005, 23:189-199.
2. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004, 61:774-780.
3. Meyer U., Feldon J., Fatemi S.H. In vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 2009, 33:1061-1079.
4. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009, 204:313-321.
5. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
6. Triantafilou M., Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002, 23:301-304.
7. Fortier M.E., Joober R., Luheshi G.N., Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 2004, 38:335-345.
8. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006, 26:4752-4762.
9. Takeuchi O., Akira S. Recognition of viruses by innate immunity. Immunol Rev 2007, 220:214-224.
10. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 2002, 26:204-215.
11. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 2008, 33:441-456.
12. Meyer U., Nyffeler M., Yee B.K., Knuesel I., Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 2008, 22:469-486.
13. Kirsten T.B., Taricano M., Maiorka P.C., Palermo-Neto J., Bernardi M.M. Prenatal lipopolysaccharide reduces social behavior in male offspring. Neuroimmunomodulation 2010, 17:240-251.
14. Kirsten T.B., Taricano M., Florio J.C., Palermo-Neto J., Bernardi M.M. Prenatal lipopolysaccharide reduces motor activity after an immune challenge in adult male offspring. Behav Brain Res 2010, 211:77-82.
15. Vuillermot S., Weber L., Feldon J., Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 2010, 30:1270-1287.
16. Castall B., Marsden C.D., Naylor R.J., Pycock C.J. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei. Brain Res 1977, 123:89-111.
17. Porrino L.J., Lucignani G., Dow-Edwards D., Sokoloff L. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res 1984, 307:311-320.
18. Laruelle M., Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol 1999, 13:358-371.
19. Laruelle M., Abi-Dargham A., Gil R., Kegeles L., Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 1999, 46:56-72.
20. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996, 93:9235-9240.
21. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997, 25:192-216.
22. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
23. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 1976, 260:731-732.
24. Segal D.S., Mandell A.J. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 1974, 2:249-255.
25. Masur J., Oliveira de Souza M.L., Zwicker A.P. The excitatory effect of ethanol: absence in rats, no tolerance and increased sensitivity in mice. Pharmacol Biochem Behav 1986, 24:1225-1228.
26. Babbini M., Davis W.M. Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br J Pharmacol 1972, 46:213-224.
27. Domino E.F. Nicotine induced behavioral locomotor sensitization. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:59-71.
28. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
29. Robinson T.E., Berridge K.C. Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 2008, 363:3137-3146.
30. Sanchis-Segura C., Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 2006, 11:2-38.
31. Golan H., Stilman M., Lev V., Huleihel M. Normal aging of offspring mice of mothers with induced inflammation during pregnancy. Neuroscience 2006, 141:1909-1918.
32. Golan H.M., Lev V., Hallak M., Sorokin Y., Huleihel M. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 2005, 48:903-917.
33. Hava G., Vered L., Yael M., Mordechai H., Mahoud H. Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy. Dev Psychobiol 2006, 48:162-168.
34. Kameda S.R., Fukushiro D.F., Trombin T.F., Procopio-Souza R., Patti C.L., Hollais A.W., et al. Adolescent mice are more vulnerable than adults to single injection-induced behavioral sensitization to amphetamine. Pharmacol Biochem Behav 2011, 98:320-324.
35. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010, 167:261-280.
36. Fortier M.E., Luheshi G.N., Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 2007, 181:270-277.
37. Romero E., Guaza C., Castellano B., Borrell J. Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia. Mol Psychiatry 2010, 15:372-383.
38. Meyer U., Knuesel I., Nyffeler M., Feldon J. Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology (Berl) 2010, 208:531-543.
39. Meyer U., Spoerri E., Yee B.K., Schwarz M.J., Feldon J. Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull 2008, 36:607-623.
40. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 1975, 94:507-522.
41. Lieberman J.A., Kinon B.J., Loebel A.D. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 1990, 16:97-110.
42. Snyder S.H. Amphetamine psychosis: a model schizophrenia mediated by catecholamines. Am J Psychiatry 1973, 130:61-67.
43. Kalivas P.W., Sorg B.A., Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 1993, 4:315-334.
44. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 151:99-120.
45. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Brain Res Rev 2003, 41:203-228.
46. Paulson P.E., Robinson T.E. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 1995, 19:56-65.
47. Robinson T.E., Jurson P.A., Bennett J.A., Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 1988, 462:211-222.
48. Burechailo L., Martin-Iverson M.T. Behavioral sensitization to cocaine, but not cocaine-conditioned behavior, is associated with increased dopamine occupation of its receptors in the nucleus accumbens. Behav Neurosci 1996, 110:1388-1396.
49. Fontana D., Post R.M., Weiss S.R., Pert A. The role of D1 and D2 dopamine receptors in the acquisition and expression of cocaine-induced conditioned increases in locomotor behavior. Behav Pharmacol 1993, 4:375-387.
50. Fontana D.J., Post R.M., Pert A. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res 1993, 629:31-39.
51. Kabbaj M., Isgor C., Watson S.J., Akil H. Stress during adolescence alters behavioral sensitization to amphetamine. Neuroscience 2002, 113:395-400.
52. Glatt S.J., Bolanos C.A., Trksak G.H., Crowder-Dupont C., Jackson D. Prenatal cocaine exposure alters behavioral and neurochemical sensitization to amphetamine in adult rats. Neuropharmacology 2000, 39:599-610.
53. Clifford P.S., Hart N., Thompson J., Buckman S., Wellman P.J., Bratton G.R., et al. Prenatal lead exposure enhances methamphetamine sensitization in rats. Pharmacol Biochem Behav 2009, 93:165-169.
54. Naef L., Srivastava L., Gratton A., Hendrickson H., Owens S.M., Walker C.D. Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology (Berl) 2008, 197:83-94.
55. Aguilar-Valles A., Flores C., Luheshi G.N. Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia. PLoS ONE 2010, 5:e10967.
56. Girard S., Kadhim H., Beaudet N., Sarret P., Sebire G. Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: a novel animal model for cerebral palsy in very premature infants. Neuroscience 2009, 158:673-682.
57. Prandota J. Possible pathomechanisms of sudden infant death syndrome: key role of chronic hypoxia, infection/inflammation states, cytokine irregularities, and metabolic trauma in genetically predisposed infants. Am J Ther 2004, 11:517-546.
58. Crombag H.S., Badiani A., Maren S., Robinson T.E. The role of contextual versus discrete drug-associated cues in promoting the induction of psychomotor sensitization to intravenous amphetamine. Behav Brain Res 2000, 116:1-22.
59. Tirelli E., Terry P. Amphetamine-induced conditioned activity and sensitization: the role of habituation to the test context and the involvement of Pavlovian processes. Behav Pharmacol 1998, 9:409-419.
60. Ahmed S.H., Oberling P., Di Scala G., Sandner G. Amphetamine-induced conditioned activity does not result from a failure of rats to habituate to novelty. Psychopharmacology (Berl) 1996, 123:325-332.
61. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 1993, 4:289-312.
62. Tirelli E., Heidbreder C. Conditioning of and contextual sensitization to apomorphine-induced climbing in mice: evidence against the habituation hypothesis. Behav Neurosci 1999, 113:368-376.
63. Free R.B., Hazelwood L.A., Cabrera D.M., Spalding H.N., Namkung Y., Rankin M.L., et al. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin. J Biol Chem 2007, 282:21285-21300.
64. Zager A., Andersen M.L., Lima M.M., Reksidler A.B., Machado R.B., Tufik S. Modulation of sickness behavior by sleep: the role of neurochemical and neuroinflammatory pathways in mice. Eur Neuropsychopharmacol 2009, 19:589-602.